[ET Net News Agency, 3 July 2025] SINO BIOPHARM (01177) rose 3% to HK$5.49.
It hits an intra-day high of HK$5.49, and an intra-day low of HK$5.33. The total shares
traded was 25.15 million, with a value of HK$135.5m. The active buy/sell ratio is 72:28,
with net buying turnover of HK$49.5m. CLSA LTD accounts for greatest net responsive buying
turnover of HK$4.12m, with volume weighted average price of HK$5.38. ABN AMRO CLEARING HK
accounts for greatest net responsive selling turnover of HK$7.03m, with volume weighted
average price of HK$5.381. The stock has risen a combined 4.4% over the past 2 consecutive
trading days.
The Hang Seng Index now fell 172 points, or 0.7% to 24,048.

Basic Information
=================

---------------------------------
Nominal 5.490 % Chg +3.00%
High 5.490 Low 5.330
Shares Tr 25.15m Turnover 135.5m
10-D SMA 5.202 %H.V 73.953
20-D SMA 5.078 VWAP 5.388
50-D SMA 4.447 RSI14 68.371
---------------------------------
Status: Active buy/sell ratio is 72:28, with net buying turnover of HK$49.5m, rising a
combined 4.4% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
SINO BIOPHARM (01177) 5.49 +3.00
3SBIO (01530) 24.35 +0.41
EVEREST MED (01952) 65.50 +2.74
KEYMED BIO-B (02162) 46.80 +2.30
WUXI XDC (02268) 43.10 +2.99
ASCENTAGE-B (06855) 83.25 +6.59
SKB BIO-B (06990) 342.00 +3.95
ZAI LAB (09688) 29.40 +5.57
AKESO (09926) 97.40 +4.96
REMEGEN (09995) 56.60 +2.44
---------------------------------------------
(ed)